Some studies have shown that HDAC inhibitors induced cell apoptosis and decreased cell viability in liver cancer [18], however more evidence is required to elucidate the molecular mechanism behind this effect and cancer cell resistance to HDAC inhibitors. The gene discussed is HDAC9; the disease is liver cancer.